XML 14 R2.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Revenues:        
Revenues $ 1,524,485 $ 941,293 $ 3,039,592 $ 1,799,728
Costs and expenses:        
Cost of sales 184,520 135,740 347,017 230,832
Research and development expenses 420,928 379,091 869,456 718,581
Sales, general and administrative expenses 191,804 156,502 374,062 303,547
Change in fair value of contingent consideration 9,200 0 10,800 0
Total costs and expenses 806,452 671,333 1,601,335 1,252,960
Income from operations 718,033 269,960 1,438,257 546,768
Interest income 4,243 18,076 16,819 33,691
Interest expense (13,871) (14,837) (28,007) (29,705)
Other income, net 116,365 53,939 55,235 96,549
Income before (benefit from) provision for income taxes 824,770 327,138 1,482,304 647,303
(Benefit from) provision for income taxes (12,500) 59,711 42,281 111,245
Net income $ 837,270 $ 267,427 $ 1,440,023 $ 536,058
Net income per common share:        
Basic (in dollars per share) $ 3.22 $ 1.04 $ 5.54 $ 2.09
Diluted (in dollars per share) $ 3.18 $ 1.03 $ 5.46 $ 2.06
Shares used in per share calculations:        
Basic (in shares) 259,637 256,154 260,013 255,941
Diluted (in shares) 263,403 259,822 263,746 260,015
Product revenues, net        
Revenues:        
Revenues $ 1,524,485 $ 940,380 $ 3,039,592 $ 1,797,633
Collaborative and royalty revenues        
Revenues:        
Revenues $ 0 $ 913 $ 0 $ 2,095